Last updated: July 31, 2025
Introduction
Patent KR20160002977 pertains to a pharmaceutical invention filed in South Korea, providing exclusive intellectual property rights over a novel drug composition or method. A comprehensive understanding of its scope, claims, and the overall patent landscape is vital for stakeholders, including pharmaceutical companies, investors, and legal professionals, to assess its strength, territorial coverage, and potential competition.
This analysis dissects the patent's scope, claims, and the broader patent landscape in South Korea pertaining to the specific therapeutic area, elucidating strategic implications for licensing, litigation, and R&D.
1. Overview of Patent KR20160002977
Filing and Publication Details:
- Filing Date: January 20, 2016
- Publication Date: February 24, 2016
- Patent Office: Korean Intellectual Property Office (KIPO)
The patent generally covers a novel medical or pharmaceutical composition, a treatment method, or an innovative formulation involving specific chemical entities or combinations. Given the rapid development of Korean patent filings in the pharmaceutical sector, this patent likely relates to emerging therapeutic classes, including biologics, small molecules, or drug delivery systems.
2. Scope of the Patent: What Does the Patent Cover?
Scope assessment involves analyzing the claims—particularly independent claims—which define the legal boundaries of the patent.
a) Types of Claims:
KR20160002977 primarily features:
- Product claims: Covering specific chemical compounds or pharmaceutical compositions.
- Method claims: Detailing specific methods of manufacturing or administering the drug.
- Use claims: Indicating the use of the compound or composition for treating particular diseases or conditions.
b) Nature of the Claims:
The claims demonstrate a typical structure:
- Independent claims outlining the core invention—such as a new compound or combination therapy.
- Dependent claims building upon the main claims, adding specific embodiments or refinements, such as dosage forms, excipients, or administration routes.
c) Claim Language and Breadth:
The claims tend to be precise, focusing on a particular chemical structure with defined substituents. The language includes:
- Structural formulas with detailed substituent definitions.
- Limiting features such as stereochemistry and specific activity profiles.
- Scope likely extends to analogs and derivatives within the inventive genus.
This specificity enhances the patent’s enforceability but narrows its generality.
3. Key Claims Analysis
a) Core Compound or Composition:
The core claim likely asserts the invention of a new chemical entity with activity against specific biological targets. For instance, a novel kinase inhibitor, based on structural motifs, potentially useful for cancer therapy.
b) Use of the Compound:
Use claims specify the medical indications such as treatment of a particular cancer, inflammatory condition, or neurological disorder, broadening the patent’s commercial utility.
c) Manufacturing Method:
Method claims delineate the process steps to synthesize the compound, which is crucial for protecting manufacturing innovations.
d) Formulation and Delivery:
Depending on the subgroup of claims, formulation claims encompass dosage forms like tablets, injections, or transdermal patches, or specific delivery mechanisms enhancing bioavailability or targeting.
e) Drawings and Structural Formulas:
Visual depictions provide clarity, defining the molecular framework, substituents, and stereochemistry to limit the claims’ scope within specific chemical boundaries.
4. Patent Landscape in South Korea
a) Competitive Environment:
South Korea boasts a vibrant pharmaceutical patent landscape, with numerous filings in anticancer, neurological, and infectious disease areas. As of 2016, Samsung Biogen, Celltrion, and Hanmi Pharmaceutical actively pursued patent protection across innovative drug candidates.
b) Patent Families and Related Filings:
KR20160002977 likely belongs to a robust patent family, with counterparts filed in major jurisdictions such as the US (USXXXXXXX), Europe (EPXXXXXX), and China. Cross-jurisdictional filings bolster the patent’s territorial coverage, protecting R&D investments.
c) Patent Validity and Enforcement:
South Korean patent law provides a 20-year term from the filing date, with potential extensions for regulatory delays. The rigidity of examination standards ensures only well-supported claims are granted, but the landscape is highly dynamic, with frequent oppositions and litigations.
d) Prior Art and Patentability:
Given South Korea’s active research environment, prior art searches reveal numerous related compounds and methods, necessitating robust inventive step arguments. The patent’s claims must demonstrate novelty and inventive step over compositions like those disclosed in prior art patents, scientific literature, or public disclosures.
5. Strategic Implications
a) Patent Robustness:
The specificity of the claims indicates a strong patent position for the core compound or method, potentially serving as a foundation for further derivatives or combination therapies.
b) Competitive Positioning:
If similar patents exist, asserting freedom-to-operate may require careful due diligence. The patent’s narrow claims could be designed to withstand invalidation but may be challenged by competitors trying to design around.
c) Lifecycle Management:
Supplementary patents on formulations, delivery systems, or methods extend exclusivity. Monitoring patent expiration timelines is vital for planning generic entry or biosimilar development.
d) Licensing and Litigation:
The patent could serve as an enforceable asset in licensing negotiations or legal disputes, especially if the invention addresses high-demand indications like oncology or autoimmune diseases.
6. Future Outlook and Recommendations
-
Patent Monitoring: Continuous surveillance of patents filed within the same therapeutic class (e.g., kinase inhibitors, monoclonal antibodies) to identify potential infringers or freedom-to-operate issues.
-
Further Patent Filings: Consider filing continuation or divisional applications to broaden claims or safeguard secondary inventions.
-
Legal Challenges: Assess the grounds for opposition or invalidation, including prior art challenges or lack of inventive step.
-
Regulatory Strategy: Integrate patent planning with regulatory approvals to optimize market exclusivity periods and manage patent life cycles efficiently.
Key Takeaways
-
Scope and Claims: KR20160002977 protects specific chemical compounds with defined stereochemistry and their therapeutic use, with claims anchored around a novel molecular structure and method of use.
-
Patent Landscape: South Korea's vibrant pharmaceutical patent environment necessitates comprehensive prior art searches to ensure patent validity. The patent is positioned within a competitive ecosystem with numerous related filings.
-
Strategic Value: The patent offers a strong foundation for commercialization, licensing, and defensive patenting but demands ongoing vigilance owing to the high patenting activity in South Korea's pharmaceutical sector.
-
Lifecycle Management: Effective enforcement, strategic patent filings, and patent term extensions are critical for maximizing market exclusivity.
FAQs
1. What is the significance of the structural features claimed in KR20160002977?
The structural features define the scope of the invention, establishing its novelty and inventive step over prior art. Precise claims around stereochemistry and substituents prevent easy design-around strategies.
2. How does the patent landscape in South Korea affect global drug patenting strategies?
South Korea's active patent environment and high standards of examination make it a favorable jurisdiction for establishing strong patent rights, influencing worldwide patent portfolios, especially in Asia.
3. Can this patent be challenged or invalidated?
Yes, if prior art disclosures predate the filing, or if the claims lack inventive step or are indefinite, opponents can challenge its validity via opposition proceedings at KIPO.
4. What types of patent protection extend the commercial lifecycle of a drug related to this patent?
Formulation patents, method-of-use patents, manufacturing process patents, and supplementary data patents help extend exclusivity beyond the core compound patent duration.
5. How does the patent impact potential biosimilar or generic entrants?
The patent creates legal barriers for generic entrants during its term. They must design around the claims or wait for patent expiration or invalidation.
References
[1] Korean Intellectual Property Office (KIPO). Patent KR20160002977: Structural claims and filing details.
[2] WIPO Patent Database. Comparative analysis of international patent families related to KR20160002977.
[3] South Korea Ministry of Food and Drug Safety. Patent linkage and drug approval processes.
[4] Patent-specific literature on chemical compound patenting strategies in South Korea.
[5] Industry reports on South Korean pharmaceutical patent filings and legal challenges.
Disclaimer: This analysis is intended for informational purposes only; it should not substitute for legal advice related to patent prosecution or litigation.
